9 Meters Biopharma Inc. (NMTRQ)
OTCMKTS: NMTRQ · Delayed Price · USD
0.00
0.00 (0.00%)
Apr 26, 2024, 4:00 PM EDT - Market closed
9 Meters Biopharma Statistics
Total Valuation
NMTRQ has a market cap or net worth of $1,446. The enterprise value is -$2.52 million.
Market Cap | 1,446 |
Enterprise Value | -2.52M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 1.71% |
Owned by Institutions (%) | 23.54% |
Float | 13.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.59
Current Ratio | 0.59 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -12.53 |
Financial Efficiency
Return on equity (ROE) is -585.00%.
Return on Equity (ROE) | -585.00% |
Return on Assets (ROA) | -159.50% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.63M |
Employee Count | 10 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | 1.21 |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | 0.02 |
Relative Strength Index (RSI) | 33.93 |
Average Volume (30 Days) | n/a |
Short Selling Information
Short Interest | 580,635 |
Short Previous Month | 578,948 |
Short % of Shares Out | n/a |
Short % of Float | 4.41% |
Short Ratio (days to cover) | 14.12 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -43.44M |
Pretax Income | -46.28M |
Net Income | -46.28M |
EBITDA | -42.86M |
EBIT | -42.86M |
Earnings Per Share (EPS) | -$3.46 |
Balance Sheet
The company has $7.62 million in cash and $5.11 million in debt, giving a net cash position of $2.52 million.
Cash & Cash Equivalents | 7.62M |
Total Debt | 5.11M |
Net Cash | 2.52M |
Net Cash Per Share | n/a |
Equity / Book Value | -6.30M |
Book Value Per Share | n/a |
Working Capital | -6.38M |
Cash Flow
Operating Cash Flow | -37.24M |
Capital Expenditures | n/a |
Free Cash Flow | -37.24M |
FCF Per Share | -$2.74 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NMTRQ does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.27% |
Shareholder Yield | -5.27% |
Earnings Yield | -3,200,769.92% |
FCF Yield | -2,575,695.85% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 18, 2022. It was a reverse split with a ratio of 1:20.
Last Split Date | Oct 18, 2022 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |